Related Experiment Video
Updated: Feb 18, 2026

Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
Pain clinics
1School of Nursing, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Abstract:
This article addresses issues related to multimodal pain programs and unimodal treatments, particularly those that deal with persistent musculoskeletal pain. Factors including prevalence, morbidity, and prognosis are examined. The research evidence for physical therapy modalities, psychological treatments, and vocational and pharmacologic interventions is critically appraised. A clinical decision algorithm for persistent pain management until referral to a multimodal chronic pain program is presented.
Related Concept Videos
Analgesia and Pain Management
Pain
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Skeletal Muscle Relaxants: Therapeutic Uses

